
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Problem or solution: The strange story of glucagon
Rebecca Scott, Stephen R. Bloom
Peptides (2018) Vol. 100, pp. 36-41
Open Access | Times Cited: 50
Rebecca Scott, Stephen R. Bloom
Peptides (2018) Vol. 100, pp. 36-41
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Glucagon Receptor Signaling and Glucagon Resistance
Lina Janah, Sasha A. S. Kjeldsen, Katrine D. Galsgaard, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3314-3314
Open Access | Times Cited: 157
Lina Janah, Sasha A. S. Kjeldsen, Katrine D. Galsgaard, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3314-3314
Open Access | Times Cited: 157
A tumor-secreted protein utilizes glucagon release to cause host wasting
Guangming Ding, Yingge Li, Cheng Chen, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Guangming Ding, Yingge Li, Cheng Chen, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
Harold Bays, Angela Fitch, Sandra Christensen, et al.
Obesity Pillars (2022) Vol. 2, pp. 100018-100018
Open Access | Times Cited: 47
Harold Bays, Angela Fitch, Sandra Christensen, et al.
Obesity Pillars (2022) Vol. 2, pp. 100018-100018
Open Access | Times Cited: 47
A combined activation mechanism for the glucagon receptor
Giulio Mattedi, Silvia Acosta‐Gutiérrez, Timothy Clark, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 27, pp. 15414-15422
Open Access | Times Cited: 65
Giulio Mattedi, Silvia Acosta‐Gutiérrez, Timothy Clark, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 27, pp. 15414-15422
Open Access | Times Cited: 65
The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes
Patrick Gilon
Journal of Molecular Biology (2020) Vol. 432, Iss. 5, pp. 1367-1394
Closed Access | Times Cited: 64
Patrick Gilon
Journal of Molecular Biology (2020) Vol. 432, Iss. 5, pp. 1367-1394
Closed Access | Times Cited: 64
Pancreatic α-cells – The unsung heroes in islet function
Anna Wendt, Lena Eliasson
Seminars in Cell and Developmental Biology (2020) Vol. 103, pp. 41-50
Open Access | Times Cited: 54
Anna Wendt, Lena Eliasson
Seminars in Cell and Developmental Biology (2020) Vol. 103, pp. 41-50
Open Access | Times Cited: 54
Recent advances in understanding the role of glucagon-like peptide 1
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
F1000Research (2020) Vol. 9, pp. 239-239
Open Access | Times Cited: 51
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
F1000Research (2020) Vol. 9, pp. 239-239
Open Access | Times Cited: 51
Proglucagon-Derived Peptides as Therapeutics
Ryan A. Lafferty, Finbarr O’Harte, Nigel Irwin, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 50
Ryan A. Lafferty, Finbarr O’Harte, Nigel Irwin, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 50
Glucagon, from past to present: a century of intensive research and controversies
André Scheen, Pierre J. Lefèbvre
The Lancet Diabetes & Endocrinology (2022) Vol. 11, Iss. 2, pp. 129-138
Closed Access | Times Cited: 30
André Scheen, Pierre J. Lefèbvre
The Lancet Diabetes & Endocrinology (2022) Vol. 11, Iss. 2, pp. 129-138
Closed Access | Times Cited: 30
Cross Talk Between Insulin and Glucagon Receptor Signaling in the Hepatocyte
Kirk M. Habegger
Diabetes (2022) Vol. 71, Iss. 9, pp. 1842-1851
Open Access | Times Cited: 24
Kirk M. Habegger
Diabetes (2022) Vol. 71, Iss. 9, pp. 1842-1851
Open Access | Times Cited: 24
Peptides in the regulation of glucagon secretion
Daniel B. Andersen, Jens J. Holst
Peptides (2021) Vol. 148, pp. 170683-170683
Open Access | Times Cited: 31
Daniel B. Andersen, Jens J. Holst
Peptides (2021) Vol. 148, pp. 170683-170683
Open Access | Times Cited: 31
Equine metabolic syndrome: Role of the enteroinsular axis in the insulin response to oral carbohydrate
Melody A. de Laat, Danielle M. Fitzgerald
The Veterinary Journal (2023) Vol. 294, pp. 105967-105967
Open Access | Times Cited: 12
Melody A. de Laat, Danielle M. Fitzgerald
The Veterinary Journal (2023) Vol. 294, pp. 105967-105967
Open Access | Times Cited: 12
Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics
Zoe Tasma, Michael L. Garelja, Aqfan Jamaluddin, et al.
Pharmacology & Therapeutics (2025), pp. 108846-108846
Open Access
Zoe Tasma, Michael L. Garelja, Aqfan Jamaluddin, et al.
Pharmacology & Therapeutics (2025), pp. 108846-108846
Open Access
Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP
Oleg G. Chepurny, Minos‐Timotheos Matsoukas, George Liapakis, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 10, pp. 3514-3531
Open Access | Times Cited: 33
Oleg G. Chepurny, Minos‐Timotheos Matsoukas, George Liapakis, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 10, pp. 3514-3531
Open Access | Times Cited: 33
Menthol to Induce Non-shivering Thermogenesis via TRPM8/PKA Signaling for Treatment of Obesity
Owen Sanders, Jayalekshmi Archa Rajagopal, Lekshmy Rajagopal
Journal of Obesity & Metabolic Syndrome (2020) Vol. 30, Iss. 1, pp. 4-11
Open Access | Times Cited: 28
Owen Sanders, Jayalekshmi Archa Rajagopal, Lekshmy Rajagopal
Journal of Obesity & Metabolic Syndrome (2020) Vol. 30, Iss. 1, pp. 4-11
Open Access | Times Cited: 28
Gastrointestinal Peptides as Therapeutic Targets to Mitigate Obesity and Metabolic Syndrome
Κλεοπάτρα Αλεξιάδου, Tricia Tan
Current Diabetes Reports (2020) Vol. 20, Iss. 7
Open Access | Times Cited: 24
Κλεοπάτρα Αλεξιάδου, Tricia Tan
Current Diabetes Reports (2020) Vol. 20, Iss. 7
Open Access | Times Cited: 24
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis
Anna Wendt, Lena Eliasson
Current Opinion in Pharmacology (2022) Vol. 63, pp. 102199-102199
Open Access | Times Cited: 15
Anna Wendt, Lena Eliasson
Current Opinion in Pharmacology (2022) Vol. 63, pp. 102199-102199
Open Access | Times Cited: 15
Linking gastrointestinal tract structure, function, and gene expression signatures to growth variability in broilers: a novel interpretation for flock uniformity
Muhammad Zeeshan Akram, Ester Arévalo Sureda, Matthias Corion, et al.
Poultry Science (2024) Vol. 103, Iss. 10, pp. 104158-104158
Open Access | Times Cited: 2
Muhammad Zeeshan Akram, Ester Arévalo Sureda, Matthias Corion, et al.
Poultry Science (2024) Vol. 103, Iss. 10, pp. 104158-104158
Open Access | Times Cited: 2
Combination gut hormones: prospects and questions for the future of obesity and diabetes therapy
Bernard Khoo, Tricia Tan
Journal of Endocrinology (2020) Vol. 246, Iss. 3, pp. R65-R74
Open Access | Times Cited: 19
Bernard Khoo, Tricia Tan
Journal of Endocrinology (2020) Vol. 246, Iss. 3, pp. R65-R74
Open Access | Times Cited: 19
The impact of macronutrient composition on metabolic regulation: An Islet‐Centric view
Klinsmann Carolo dos Santos, Camilla Olofsson, João Paulo Monteiro Carvalho Móri da Cunha, et al.
Acta Physiologica (2022) Vol. 236, Iss. 4
Open Access | Times Cited: 11
Klinsmann Carolo dos Santos, Camilla Olofsson, João Paulo Monteiro Carvalho Móri da Cunha, et al.
Acta Physiologica (2022) Vol. 236, Iss. 4
Open Access | Times Cited: 11
Effect of Glucagon on Ischemic Heart Disease and Its Risk Factors: A Mendelian Randomization Study
Jack Ng, C. Mary Schooling
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 8, pp. e2778-e2788
Open Access | Times Cited: 16
Jack Ng, C. Mary Schooling
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 8, pp. e2778-e2788
Open Access | Times Cited: 16
A glucagon analogue decreases body weight in mice via signalling in the liver
Charlotte E. Hinds, Bryn M. Owen, David C. D. Hope, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Charlotte E. Hinds, Bryn M. Owen, David C. D. Hope, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy – A review
J. Michael Conlon, Finbarr O’Harte, Peter R. Flatt
Peptides (2021) Vol. 147, pp. 170706-170706
Open Access | Times Cited: 9
J. Michael Conlon, Finbarr O’Harte, Peter R. Flatt
Peptides (2021) Vol. 147, pp. 170706-170706
Open Access | Times Cited: 9
Greater Loss of Central Adiposity from Low-Carbohydrate versus Low-Fat Diet in Middle-Aged Adults with Overweight and Obesity
Valene Garr Barry, Mariah Stewart, Taraneh Soleymani, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 475-475
Open Access | Times Cited: 8
Valene Garr Barry, Mariah Stewart, Taraneh Soleymani, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 475-475
Open Access | Times Cited: 8
Glucagon delivery – An overview of current and future devices
А. Л. Рабинович, Ronny Priefer
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102155-102155
Closed Access | Times Cited: 8
А. Л. Рабинович, Ronny Priefer
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 4, pp. 102155-102155
Closed Access | Times Cited: 8